{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T23:08:12Z","timestamp":1778454492250,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":50,"publisher":"Springer US","isbn-type":[{"value":"9781071650363","type":"print"},{"value":"9781071650370","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5037-0_4","type":"book-chapter","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:09:44Z","timestamp":1778450984000},"page":"47-90","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ImmTAC: A Novel Platform of T-Cell Receptor-Based Soluble Bispecifics"],"prefix":"10.1007","author":[{"given":"Benjamin P.","family":"Oestringer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelise","family":"Vuidepot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/curroncol29050247","volume":"29","author":"Y Shiravand","year":"2022","unstructured":"Shiravand Y, Khodadadi F, Kashani SMA et al (2022) Immune checkpoint inhibitors in cancer therapy. Curr Oncol 29:3044\u20133060. https:\/\/doi.org\/10.3390\/curroncol29050247","journal-title":"Curr Oncol"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41571-023-00754-1","volume":"20","author":"KM Cappell","year":"2023","unstructured":"Cappell KM, Kochenderfer JN (2023) Long-term outcomes following CAR T cell therapy: what we know so far. Nat Rev Clin Oncol 20:359\u2013371. https:\/\/doi.org\/10.1038\/s41571-023-00754-1","journal-title":"Nat Rev Clin Oncol"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41573-023-00709-2","volume":"22","author":"C Dumontet","year":"2023","unstructured":"Dumontet C, Reichert JM, Senter PD et al (2023) Antibody\u2013drug conjugates come of age in oncology. Nat Rev Drug Discov 22:641\u2013661. https:\/\/doi.org\/10.1038\/s41573-023-00709-2","journal-title":"Nat Rev Drug Discov"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41571-023-00850-2","volume":"21","author":"K Tsuchikama","year":"2024","unstructured":"Tsuchikama K, Anami Y, Ha SYY, Yamazaki CM (2024) Exploring the next generation of antibody\u2013drug conjugates. Nat Rev Clin Oncol 21:203\u2013223. https:\/\/doi.org\/10.1038\/s41571-023-00850-2","journal-title":"Nat Rev Clin Oncol"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM et al (2015) Tissue-based map of the human proteome. Science 347:1260419\u20131260419. https:\/\/doi.org\/10.1126\/science.1260419","journal-title":"Science"},{"key":"4_CR6","unstructured":"The human cell in plasma membrane - The Human Protein Atlas. https:\/\/www.proteinatlas.org\/humanproteome\/subcellular\/plasma+membrane. Accessed 16 Jul 2024"},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s43018-021-00282-w","volume":"2","author":"Z Hu","year":"2021","unstructured":"Hu Z, Yuan J, Long M et al (2021) The Cancer Surfaceome Atlas integrates genomic, functional and drug response data to identify actionable targets. Nat Cancer 2:1406\u20131422. https:\/\/doi.org\/10.1038\/s43018-021-00282-w","journal-title":"Nat Cancer"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nm.2764","volume":"18","author":"N Liddy","year":"2012","unstructured":"Liddy N, Bossi G, Adams KJ et al (2012) Monoclonal TCR-redirected tumor cell killing. Nat Med 18:980\u2013987. https:\/\/doi.org\/10.1038\/nm.2764","journal-title":"Nat Med"},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/protein\/gzg087","volume":"16","author":"JM Boulter","year":"2003","unstructured":"Boulter JM, Glick M, Todorov PT et al (2003) Stable, soluble T-cell receptor molecules for crystallization and therapeutics. Protein Eng Des Sel 16:707\u2013711. https:\/\/doi.org\/10.1093\/protein\/gzg087","journal-title":"Protein Eng Des Sel"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"20103","DOI":"10.1016\/S0021-9258(18)54896-1","volume":"266","author":"SJ Hughes","year":"1991","unstructured":"Hughes SJ, Johnston LH, Carlos A, de Smith GL (1991) Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae. J Biol Chem 266:20103\u201320109. https:\/\/doi.org\/10.1016\/s0021-9258(18)54896-1","journal-title":"J Biol Chem"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0378-1119(87)90165-X","volume":"56","author":"AH Rosenberg","year":"1987","unstructured":"Rosenberg AH, Lade BN, Dao-shan C et al (1987) Vectors for selective expression of cloned DNAs by T7 RNA polymerase. Gene 56:125\u2013135. https:\/\/doi.org\/10.1016\/0378-1119(87)90165-x","journal-title":"Gene"},{"key":"4_CR12","unstructured":"Karsten JB, Bent AT, Eamon MP, YI L (2014) T cell receptor display, US20140371085A1"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/eji.1830110412","volume":"11","author":"PCL Beverley","year":"1981","unstructured":"Beverley PCL, Callard RE (1981) Distinctive functional characteristics of human \u201cT\u201d lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody. Eur J Immunol 11:329\u2013334. https:\/\/doi.org\/10.1002\/eji.1830110412","journal-title":"Eur J Immunol"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1084\/jem.175.1.217","volume":"175","author":"MR Shalaby","year":"1992","unstructured":"Shalaby MR, Shepard HM, Presta L et al (1992) Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene. J Exp Medicine 175:217\u2013225. https:\/\/doi.org\/10.1084\/jem.175.1.217","journal-title":"J Exp Medicine"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1359-0278(98)00044-3","volume":"3","author":"P Kristensen","year":"1998","unstructured":"Kristensen P, Winter G (1998) Proteolytic selection for protein folding using filamentous bacteriophages. Fold Des 3:321\u2013328. https:\/\/doi.org\/10.1016\/s1359-0278(98)00044-3","journal-title":"Fold Des"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"pdb.ip85","DOI":"10.1101\/pdb.ip85","volume":"2011","author":"M-P Lefranc","year":"2011","unstructured":"Lefranc M-P (2011) IMGT unique numbering for the variable (V), constant (C), and groove (G) domains of IG, TR, MH, IgSF, and MhSF. Cold Spring Harb Protoc 2011:pdb.ip85. https:\/\/doi.org\/10.1101\/pdb.ip85","journal-title":"Cold Spring Harb Protoc"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/384134a0","volume":"384","author":"DN Garboczi","year":"1996","unstructured":"Garboczi DN, Ghosh P, Utz U et al (1996) Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134\u2013141. https:\/\/doi.org\/10.1038\/384134a0","journal-title":"Nature"},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1084\/jem.20042323","volume":"201","author":"J-L Chen","year":"2005","unstructured":"Chen J-L, Stewart-Jones G, Bossi G et al (2005) Structural and kinetic basis for heightened immunogenicity of T cell vaccines. J Exp Med 201:1243\u20131255. https:\/\/doi.org\/10.1084\/jem.20042323","journal-title":"J Exp Med"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.4049\/jimmunol.179.9.5845","volume":"179","author":"Y Zhao","year":"2007","unstructured":"Zhao Y, Bennett AD, Zheng Z et al (2007) High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines. J Immunol 179:5845\u20135854. https:\/\/doi.org\/10.4049\/jimmunol.179.9.5845","journal-title":"J Immunol"},{"key":"4_CR20","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1073\/pnas.89.8.3429","volume":"89","author":"DN Garboczi","year":"1992","unstructured":"Garboczi DN, Hung DT, Wiley DC (1992) HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc National Acad Sci 89:3429\u20133433. https:\/\/doi.org\/10.1073\/pnas.89.8.3429","journal-title":"Proc National Acad Sci"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1074\/jbc.M113.522110","volume":"289","author":"DK Cole","year":"2014","unstructured":"Cole DK, Miles KM, Madura F et al (2014) T-cell receptor (TCR)-peptide specificity overrides affinity-enhancing TCR-major histocompatibility complex interactions. J Biol Chem 289:628\u2013638. https:\/\/doi.org\/10.1074\/jbc.m113.522110","journal-title":"J Biol Chem"},{"key":"4_CR22","unstructured":"Karsten JB, Meir G (2003) Soluble T cell receptor, WO2003020763"},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nbt1070","volume":"23","author":"Y Li","year":"2005","unstructured":"Li Y, Moysey R, Molloy PE et al (2005) Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nat Biotechnol 23:349\u2013354. https:\/\/doi.org\/10.1038\/nbt1070","journal-title":"Nat Biotechnol"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"15232","DOI":"10.1074\/jbc.275.20.15232","volume":"275","author":"GF Gao","year":"2000","unstructured":"Gao GF, Willcox BE, Wyer JR et al (2000) Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8\u03b1\u03b1. J Biol Chem 275:15232\u201315238. https:\/\/doi.org\/10.1074\/jbc.275.20.15232","journal-title":"J Biol Chem"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1110\/ps.051936406","volume":"15","author":"SM Dunn","year":"2006","unstructured":"Dunn SM, Rizkallah PJ, Baston E et al (2006) Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity. Protein Sci 15:710\u2013721. https:\/\/doi.org\/10.1110\/ps.051936406","journal-title":"Protein Sci"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.molimm.2015.01.024","volume":"67","author":"J Oates","year":"2015","unstructured":"Oates J, Hassan NJ, Jakobsen BK (2015) ImmTACs for targeted cancer therapy: why, what, how, and which. Mol Immunol 67:67\u201374. https:\/\/doi.org\/10.1016\/j.molimm.2015.01.024","journal-title":"Mol Immunol"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1038\/nprot.2007.448","volume":"2","author":"CMY Lee","year":"2007","unstructured":"Lee CMY, Iorno N, Sierro F, Christ D (2007) Selection of human antibody fragments by phage display. Nat Protoc 2:3001\u20133008. https:\/\/doi.org\/10.1038\/nprot.2007.448","journal-title":"Nat Protoc"},{"key":"4_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/cei\/uxad120","volume":"215","author":"IB Robertson","year":"2023","unstructured":"Robertson IB, Mulvaney R, Dieckmann N et al (2023) Tuning the potency and selectivity of ImmTAC molecules by affinity modulation. Clin Exp Immunol 215:105\u2013119. https:\/\/doi.org\/10.1093\/cei\/uxad120","journal-title":"Clin Exp Immunol"},{"key":"4_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1074-7613(00)80035-7","volume":"10","author":"BE Willcox","year":"1999","unstructured":"Willcox BE, Gao GF, Wyer JR et al (1999) TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity 10:357\u2013365.  https:\/\/doi.org\/10.1016\/s1074-7613(00)80035-7","journal-title":"Immunity"},{"key":"4_CR30","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1110\/ps.8.11.2418","volume":"8","author":"BE Willcox","year":"1999","unstructured":"Willcox BE, Gao GF, Wyer JR et al (1999) Production of soluble \u03b1\u03b2 T-cell receptor heterodimers suitable for biophysical analysis of ligand binding. Protein Sci 8:2418\u20132423. https:\/\/doi.org\/10.1110\/ps.8.11.2418","journal-title":"Protein Sci"},{"key":"4_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/prot.21176","volume":"67","author":"DK Cole","year":"2007","unstructured":"Cole DK, Rizkallah PJ, Boulter JM et al (2007) Computational design and crystal structure of an enhanced affinity mutant human CD8 \u03b1\u03b1 coreceptor. Proteins Struct Funct Bioinform 67:65\u201374. https:\/\/doi.org\/10.1002\/prot.21176","journal-title":"Proteins Struct Funct Bioinform"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"e20221939","DOI":"10.1084\/jem.20221939","volume":"220","author":"A Chancellor","year":"2023","unstructured":"Chancellor A, Simmons RA, Khanolkar RC et al (2023) Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responses. J Exp Med 220:e20221939. https:\/\/doi.org\/10.1084\/jem.20221939","journal-title":"J Exp Med"},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"18851","DOI":"10.1038\/srep18851","volume":"6","author":"MCC Raman","year":"2016","unstructured":"Raman MCC, Rizkallah PJ, Simmons R et al (2016) Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy. Sci Rep-UK 6:18851. https:\/\/doi.org\/10.1038\/srep18851","journal-title":"Sci Rep-UK"},{"key":"4_CR34","doi-asserted-by":"publisher","first-page":"27281","DOI":"10.1074\/jbc.M109.022509","volume":"284","author":"DK Cole","year":"2009","unstructured":"Cole DK, Yuan F, Rizkallah PJ et al (2009) Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor. J Biol Chem 284:27281\u201327289. https:\/\/doi.org\/10.1074\/jbc.m109.022509","journal-title":"J Biol Chem"},{"key":"4_CR35","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/eji.200535424","volume":"36","author":"DK Cole","year":"2006","unstructured":"Cole DK, Rizkallah PJ, Gao F et al (2006) Crystal structure of HLA-A*2402 complexed with a telomerase peptide. Eur J Immunol 36:170\u2013179. https:\/\/doi.org\/10.1002\/eji.200535424","journal-title":"Eur J Immunol"},{"key":"4_CR36","doi-asserted-by":"publisher","first-page":"32786","DOI":"10.1074\/jbc.M102498200","volume":"276","author":"MA Purbhoo","year":"2001","unstructured":"Purbhoo MA, Boulter JM, Price DA et al (2001) The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the t cell receptor \u03b6 chain. J\u00a0Biol Chem 276:32786\u201332792. https:\/\/doi.org\/10.1074\/jbc.m102498200","journal-title":"J Biol Chem"},{"key":"4_CR37","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1016\/j.molimm.2007.12.009","volume":"45","author":"DK Cole","year":"2008","unstructured":"Cole DK, Dunn SM, Sami M et al (2008) T cell receptor engagement of peptide-major histocompatibility complex class I does not modify CD8 binding. Mol Immunol 45:2700\u20132709. https:\/\/doi.org\/10.1016\/j.molimm.2007.12.009","journal-title":"Mol Immunol"},{"key":"4_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1006\/abio.1998.2930","volume":"266","author":"CA O\u2019Callaghan","year":"1999","unstructured":"O\u2019Callaghan CA, Byford MF, Wyer JR et al (1999) BirA enzyme: production and application in the study of membrane receptor\u2013ligand interactions by site-specific biotinylation. Anal Biochem 266:9\u201315. https:\/\/doi.org\/10.1006\/abio.1998.2930","journal-title":"Anal Biochem"},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"ji1900915","DOI":"10.4049\/jimmunol.1900915","volume":"204","author":"CH Coles","year":"2020","unstructured":"Coles CH, Mulvaney RM, Malla S et al (2020) TCRs\u00a0with distinct specificity profiles use different\u00a0binding modes to engage an identical peptide\u2013HLA complex. J Immunol 204:ji1900915. https:\/\/doi.org\/10.4049\/jimmunol.1900915","journal-title":"J Immunol"},{"key":"4_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32811-1","volume":"13","author":"A Poole","year":"2022","unstructured":"Poole A, Karuppiah V, Hartt A et al (2022) Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen. Nat Commun 13: 5333. https:\/\/doi.org\/10.1038\/s41467-022-32811-1","journal-title":"Nat Commun"},{"key":"4_CR41","unstructured":"Cytivia kinetics and affinity measurements with Biacore systems. https:\/\/cdn.cytivalifesciences.com\/api\/public\/content\/digi-33041-pdf. Accessed 19 Jul 2024"},{"key":"4_CR42","unstructured":"Michael BJ (2009) Gamma-delta T cell receptors, US20090105133"},{"key":"4_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0076-6879(87)53044-0","volume":"153","author":"J Vieira","year":"1987","unstructured":"Vieira J, Messing J (1987) Production of single-stranded plasmid DNA. Methods Enzym 153:3\u201311. https:\/\/doi.org\/10.1016\/0076-6879(87)53044-0","journal-title":"Methods Enzym"},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.3389\/fimmu.2020.01986","volume":"11","author":"MA Alfaleh","year":"2020","unstructured":"Alfaleh MA, Alsaab HO, Mahmoud AB et al (2020) Phage display derived monoclonal antibodies: from bench to bedside. Front Immunol 11:1986. https:\/\/doi.org\/10.3389\/fimmu.2020.01986","journal-title":"Front Immunol"},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.3390\/v15091903","volume":"15","author":"RKA Fran\u00e7a","year":"2023","unstructured":"Fran\u00e7a RKA, Studart IC, Bezerra MRL et al (2023) Progress on phage display technology: tailoring antibodies for cancer immunotherapy. Viruses 15:1903. https:\/\/doi.org\/10.3390\/v15091903","journal-title":"Viruses"},{"key":"4_CR46","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1002\/cpps.66","volume":"94","author":"H Kim","year":"2018","unstructured":"Kim H, Ho M (2018) Isolation of antibodies to heparan sulfate on glypicans by phage display. Curr Protoc Protein Sci 94:e66. https:\/\/doi.org\/10.1002\/cpps.66","journal-title":"Curr Protoc Protein Sci"},{"key":"4_CR47","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/0003-2697(89)90250-9","volume":"181","author":"WL Hoffman","year":"1989","unstructured":"Hoffman WL, Jump AA (1989) Inhibition of the streptavidin-biotin interaction by milk. Anal Biochem 181:318\u2013320. https:\/\/doi.org\/10.1016\/0003-2697(89)90250-9","journal-title":"Anal Biochem"},{"key":"4_CR48","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ab.2003.12.011","volume":"326","author":"R Moysey","year":"2004","unstructured":"Moysey R, Vuidepot A-L, Boulter JM (2004) Amplification and one-step expression cloning of human T cell receptor genes. Anal Biochem 326:284\u2013286. https:\/\/doi.org\/10.1016\/j.ab.2003.12.011","journal-title":"Anal Biochem"},{"key":"4_CR49","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/eji.201948085","volume":"49","author":"F Madura","year":"2019","unstructured":"Madura F, Rizkallah PJ, Legut M et al (2019) TCR-induced alteration of primary MHC peptide anchor residue. Eur J Immunol 49:1052\u20131066. https:\/\/doi.org\/10.1002\/eji.201948085","journal-title":"Eur J Immunol"},{"key":"4_CR50","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1002\/eji.201242606","volume":"42","author":"M Aleksic","year":"2012","unstructured":"Aleksic M, Liddy N, Molloy PE et al (2012) Different affinity windows for virus and cancer-specific T-cell receptors: Implications for therapeutic strategies. Eur J Immunol 42:3174\u20133179. https:\/\/doi.org\/10.1002\/eji.201242606","journal-title":"Eur J Immunol"}],"container-title":["Methods in Molecular Biology","Bispecific Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5037-0_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:09:45Z","timestamp":1778450985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5037-0_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071650363","9781071650370"],"references-count":50,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5037-0_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}